Danaher Gross Margin 2012-2026 | DHR
Current and historical gross margin for Danaher (DHR) over the last 10 years. The current gross profit margin for Danaher as of March 31, 2026 is %.
| Danaher Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2026-03-31 | $24.78B | $14.60B | 58.94% |
| 2025-12-31 | $24.57B | $14.52B | 59.11% |
| 2025-09-30 | $24.27B | $14.45B | 59.53% |
| 2025-06-30 | $24.01B | $14.33B | 59.66% |
| 2025-03-31 | $23.82B | $14.23B | 59.74% |
| 2024-12-31 | $23.88B | $14.21B | 59.50% |
| 2024-09-30 | $23.74B | $14.10B | 59.37% |
| 2024-06-30 | $23.57B | $13.97B | 59.27% |
| 2024-03-31 | $23.74B | $13.86B | 58.39% |
| 2023-12-31 | $23.89B | $14.03B | 58.74% |
| 2023-09-30 | $21.03B | $12.43B | 59.13% |
| 2023-06-30 | $23.07B | $13.74B | 59.58% |
| 2023-03-31 | $24.90B | $15.15B | 60.81% |
| 2022-12-31 | $26.64B | $16.19B | 60.76% |
| 2022-09-30 | $26.60B | $16.24B | 61.05% |
| 2022-06-30 | $26.17B | $16.02B | 61.21% |
| 2022-03-31 | $25.63B | $15.69B | 61.22% |
| 2021-12-31 | $24.80B | $15.24B | 61.44% |
| 2021-09-30 | $28.07B | $16.96B | 60.44% |
| 2021-06-30 | $26.72B | $15.83B | 59.24% |
| 2021-03-31 | $24.80B | $14.29B | 57.60% |
| 2020-12-31 | $22.28B | $12.48B | 55.98% |
| 2020-09-30 | $20.39B | $11.23B | 55.05% |
| 2020-06-30 | $18.89B | $10.44B | 55.28% |
| 2020-03-31 | $18.03B | $10.07B | 55.85% |
| 2019-12-31 | $17.91B | $9.98B | 55.74% |
| 2019-09-30 | $15.56B | $8.63B | 55.48% |
| 2019-06-30 | $16.04B | $8.88B | 55.39% |
| 2019-03-31 | $16.57B | $9.22B | 55.61% |
| 2018-12-31 | $17.05B | $9.51B | 55.76% |
| 2018-09-30 | $16.80B | $9.37B | 55.76% |
| 2018-06-30 | $16.48B | $9.22B | 55.93% |
| 2018-03-31 | $16.01B | $8.88B | 55.48% |
| 2017-12-31 | $15.52B | $8.57B | 55.23% |
| 2017-09-30 | $17.83B | $9.85B | 55.27% |
| 2017-06-30 | $17.43B | $9.60B | 55.08% |
| 2017-03-31 | $17.16B | $9.50B | 55.35% |
| 2016-12-31 | $16.88B | $9.33B | 55.29% |
| 2016-09-30 | $13.57B | $7.60B | 56.02% |
| 2016-06-30 | $12.95B | $7.21B | 55.67% |
| 2016-03-31 | $13.66B | $7.47B | 54.67% |
| 2015-12-31 | $14.43B | $7.77B | 53.83% |
| 2015-09-30 | $18.58B | $9.81B | 52.78% |
| 2015-06-30 | $19.78B | $10.37B | 52.42% |
| 2015-03-31 | $19.78B | $10.34B | 52.29% |
| 2014-12-31 | $19.75B | $10.33B | 52.30% |
| 2014-09-30 | $19.60B | $10.24B | 52.23% |
| 2014-06-30 | $19.56B | $10.21B | 52.19% |
| 2014-03-31 | $19.34B | $10.09B | 52.16% |
| 2013-12-31 | $19.12B | $9.96B | 52.09% |
| 2013-09-30 | $18.83B | $9.79B | 52.01% |
| 2013-06-30 | $18.57B | $9.65B | 51.93% |
| 2013-03-31 | $18.39B | $9.51B | 51.69% |
| 2012-12-31 | $18.26B | $9.42B | 51.56% |
| 2012-09-30 | $18.00B | $9.20B | 51.09% |
| 2012-06-30 | $18.03B | $9.10B | 50.47% |
| 2012-03-31 | $17.12B | $8.66B | 50.62% |
| 2011-12-31 | $16.09B | $8.18B | 50.82% |
| 2011-09-30 | $14.61B | $7.57B | 51.81% |
| 2011-06-30 | $13.25B | $7.00B | 52.80% |
| 2011-03-31 | $12.83B | $6.69B | 52.09% |
| 2010-12-31 | $12.55B | $6.41B | 51.04% |
| 2010-09-30 | $11.78B | $5.92B | 50.20% |
| 2010-06-30 | $11.44B | $5.62B | 49.16% |
| 2010-03-31 | $10.90B | $5.28B | 48.45% |
| 2009-12-31 | $10.52B | $5.07B | 48.20% |
| 2009-09-30 | $11.23B | $5.29B | 47.14% |
| 2009-06-30 | $11.69B | $5.48B | 46.92% |
| 2009-03-31 | $12.30B | $5.78B | 47.02% |
| 2008-12-31 | $12.70B | $5.94B | 46.79% |
| 2008-09-30 | $12.66B | $5.94B | 46.91% |
| 2008-06-30 | $12.19B | $5.68B | 46.60% |
| 2008-03-31 | $11.53B | $5.32B | 46.12% |
| 2007-12-31 | $11.03B | $5.04B | 45.72% |
| 2007-09-30 | $10.45B | $4.75B | 45.45% |
| 2007-06-30 | $10.13B | $4.59B | 45.32% |
| 2007-03-31 | $9.84B | $4.42B | 44.90% |
| 2006-12-31 | $9.47B | $4.20B | 44.34% |
| 2006-09-30 | $9.05B | $3.97B | 43.85% |
| 2006-06-30 | $8.61B | $3.73B | 43.31% |
| 2006-03-31 | $8.19B | $3.55B | 43.31% |
| 2005-12-31 | $7.87B | $3.41B | 43.25% |
| 2005-09-30 | $7.70B | $3.31B | 42.97% |
| 2005-06-30 | $7.48B | $3.20B | 42.79% |
| 2005-03-31 | $7.17B | $3.04B | 42.35% |
| 2004-12-31 | $6.89B | $2.89B | 41.99% |
| 2004-09-30 | $6.40B | $2.66B | 41.59% |
| 2004-06-30 | $5.96B | $2.46B | 41.33% |
| 2004-03-31 | $5.64B | $2.30B | 40.83% |
| 2003-12-31 | $5.29B | $2.14B | 40.41% |
| 2003-09-30 | $5.08B | $2.04B | 40.19% |
| 2003-06-30 | $4.92B | $1.96B | 39.78% |
| 2003-03-31 | $4.77B | $1.88B | 39.36% |
| 2002-12-31 | $4.58B | $1.79B | 39.02% |
| 2002-09-30 | $4.22B | $1.62B | 38.33% |
| 2002-06-30 | $3.97B | $1.51B | 38.08% |
| 2002-03-31 | $3.78B | $1.44B | 38.15% |
| 2001-12-31 | $3.78B | $1.44B | 38.17% |
| 2001-09-30 | $3.90B | $1.50B | 38.55% |
| 2001-06-30 | $3.98B | $1.54B | 38.56% |
| 2001-03-31 | $3.92B | $1.51B | 38.57% |
| 2000-12-31 | $3.78B | $1.46B | 38.72% |
| 2000-09-30 | $3.59B | $1.36B | 37.95% |
| 2000-06-30 | $3.39B | $1.29B | 38.01% |
| 2000-03-31 | $3.24B | $1.22B | 37.69% |
| 1999-12-31 | $3.13B | $1.17B | 37.29% |
| 1999-09-30 | $3.08B | $1.07B | 34.56% |
| 1999-06-30 | $3.03B | $1.04B | 34.31% |
| 1999-03-31 | $3.02B | $1.08B | 35.84% |
| 1998-12-31 | $2.91B | $1.09B | 37.42% |
| 1998-09-30 | $2.78B | $1.19B | 42.67% |
| 1998-06-30 | $2.68B | $1.19B | 44.19% |
| 1998-03-31 | $2.56B | $1.13B | 44.17% |
| 1997-12-31 | $2.49B | $1.11B | 44.54% |
| 1997-09-30 | $2.31B | $0.98B | 42.22% |
| 1997-06-30 | $2.16B | $0.84B | 39.06% |
| 1997-03-31 | $1.99B | $0.71B | 35.82% |
| 1996-12-31 | $1.81B | $0.57B | 31.55% |
| 1996-09-30 | $1.75B | $0.64B | 36.77% |
| 1996-06-30 | $1.68B | $0.61B | 36.25% |
| 1996-03-31 | $1.60B | $0.55B | 34.13% |
| 1995-12-31 | $1.52B | $0.48B | 31.71% |
| 1995-09-30 | $1.45B | $0.35B | 24.10% |
| 1995-06-30 | $1.37B | $0.33B | 23.89% |
| 1995-03-31 | $1.34B | $0.34B | 25.54% |
| 1994-12-31 | $1.29B | $0.36B | 27.56% |
| 1994-09-30 | $1.22B | $0.33B | 27.30% |
| 1994-06-30 | $1.18B | $0.31B | 26.64% |
| 1994-03-31 | $1.12B | $0.29B | 26.34% |
| 1993-12-31 | $1.08B | $0.28B | 26.23% |
| 1993-09-30 | $1.05B | $0.28B | 26.69% |
| 1993-06-30 | $1.01B | $0.27B | 26.63% |
| 1993-03-31 | $0.99B | $0.26B | 26.21% |
| 1992-12-31 | $0.96B | $0.25B | 25.94% |
| 1992-09-30 | $0.91B | $0.22B | 23.88% |
| 1992-06-30 | $0.88B | $0.20B | 23.20% |
| 1992-03-31 | $0.84B | $0.20B | 23.21% |
| 1991-12-31 | $0.83B | $0.20B | 23.56% |
| 1991-09-30 | $0.85B | $0.22B | 25.53% |
| 1991-06-30 | $0.87B | $0.23B | 26.96% |
| 1991-03-31 | $0.87B | $0.24B | 28.08% |
| 1990-12-31 | $0.85B | $0.25B | 29.08% |
| 1990-09-30 | $0.79B | $0.24B | 29.63% |
| 1990-06-30 | $0.75B | $0.23B | 30.25% |
| 1990-03-31 | $0.74B | $0.23B | 30.82% |
| 1989-12-31 | $0.76B | $0.24B | 31.31% |
| 1989-09-30 | $0.73B | $0.24B | 32.83% |
| 1989-06-30 | $0.72B | $0.24B | 32.83% |
| 1989-03-31 | $0.72B | $0.24B | 32.78% |
| 1988-12-31 | $0.71B | $0.23B | 32.77% |
| 1988-09-30 | $0.59B | $0.21B | 36.03% |
| 1988-06-30 | $0.62B | $0.21B | 34.30% |
| 1988-03-31 | $0.62B | $0.21B | 32.85% |
| 1987-12-31 | $0.62B | $0.20B | 31.66% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $134.187B | $24.568B |
| Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of critical areas including genes, proteins, metabolites and cells to understand the causes of diseases, identify new therapies, and test new drugs and vaccines. Range of industries served includes biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial. Diagnostics segment offers analytical instruments, reagents, consumables, software and services that are deployed in reference laboratories, hospitals, physicians' offices and other critical care settings. It helps to diagnose diseases and take suitable treatment decisions. Environmental & Applied Solutions segment offers products and services that help keep food and water supplies safe globally. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCA Healthcare (HCA) | United States | $110.772B | 17.53 |
| CVS Health (CVS) | United States | $101.670B | 11.75 |
| Elevance Health (ELV) | United States | $68.432B | 10.33 |
| Cencora (COR) | United States | $62.409B | 19.63 |
| Natera (NTRA) | United States | $27.358B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.501B | 15.87 |
| DiDi Global (DIDIY) | China | $18.026B | 15.96 |
| Viatris (VTRS) | United States | $15.685B | 5.71 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.535B | 0.00 |
| Medpace Holdings (MEDP) | United States | $14.094B | 32.26 |
| BioMerieux (BMXMF) | France | $12.476B | 0.00 |
| Solventum (SOLV) | United States | $11.408B | 10.78 |
| Revvity (RVTY) | United States | $10.039B | 17.71 |
| BrightSpring Health Services (BTSG) | United States | $8.774B | 43.59 |
| Charles River Laboratories (CRL) | United States | $8.667B | 17.09 |
| ICON (ICLR) | Ireland | $8.626B | 8.56 |
| CochLear (CHEOY) | Australia | $8.030B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $6.905B | 0.00 |
| HealthEquity (HQY) | United States | $6.586B | 23.20 |
| Bausch + Lomb (BLCO) | Canada | $5.877B | 32.98 |
| GETINGE (GNGBY) | Sweden | $5.626B | 17.96 |
| Avantor (AVTR) | United States | $5.388B | 8.68 |
| PACS (PACS) | United States | $5.304B | 27.44 |
| Caris Life Sciences,�Inc (CAI) | United States | $5.101B | 0.00 |
| Sotera Health (SHC) | United States | $4.380B | 19.95 |
| Alignment Healthcare (ALHC) | United States | $4.188B | 0.00 |
| Concentras Parent (CON) | United States | $2.818B | 16.12 |
| Organon (OGN) | United States | $2.299B | 2.57 |
| Amplifon S.p.A (AMFPF) | Italy | $2.275B | 13.27 |
| Pediatrix Medical (MD) | United States | $1.782B | 11.11 |
| Establishment Labs Holdings (ESTA) | United States | $1.765B | 0.00 |
| GeneDx Holdings (WGS) | United States | $1.746B | 42.28 |
| Surgery Partners (SGRY) | United States | $1.671B | 41.65 |
| Sonida Senior Living (SNDA) | United States | $1.544B | 0.00 |
| Ardent Health (ARDT) | United States | $1.345B | 5.70 |
| Progyny (PGNY) | United States | $1.277B | 25.08 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.240B | 0.00 |
| InnovAge Holding (INNV) | United States | $1.113B | 164.00 |
| Teladoc Health (TDOC) | United States | $0.920B | 0.00 |
| CareDx (CDNA) | United States | $0.822B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.750B | 12.17 |
| Enhabit (EHAB) | United States | $0.709B | 25.89 |
| Nutex Health (NUTX) | United States | $0.704B | 11.25 |
| Omada Health (OMDA) | United States | $0.672B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.604B | 99.85 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.531B | 0.00 |
| Embecta (EMBC) | United States | $0.524B | 2.92 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| CryoPort (CYRX) | United States | $0.482B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.435B | 4.70 |
| SBC Medicals (SBC) | United States | $0.426B | 8.47 |
| Forward Industries (FWDI) | United States | $0.375B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.349B | 0.00 |
| Agilon Health (AGL) | United States | $0.316B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.309B | 0.00 |
| Oncology Institute (TOI) | United States | $0.304B | 0.00 |
| So-Young (SY) | China | $0.262B | 0.00 |
| LifeMD (LFMD) | United States | $0.166B | 0.00 |
| Biodesix (BDSX) | United States | $0.133B | 0.00 |
| Beauty Health (SKIN) | United States | $0.115B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.091B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.080B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.077B | 0.00 |
| DocGo (DCGO) | United States | $0.051B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
| Pomdoctor - (POM) | China | $0.031B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.026B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.018B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.015B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.011B | 0.00 |
| Lifeward (LFWD) | United States | $0.010B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| Aclarion (ACON) | United States | $0.007B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.007B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.005B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |